ID
16205
Description
Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00063570
Link
https://clinicaltrials.gov/show/NCT00063570
Keywords
Versions (1)
- 7/5/16 7/5/16 -
Uploaded on
July 5, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Cancer NCT00063570
Eligibility Breast Cancer NCT00063570
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Pregnancy | Breast Feeding
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Description
Metastatic malignant neoplasm to brain
Data type
boolean
Alias
- UMLS CUI [1]
- C0220650
Description
gemcitabine | pemetrexed
Data type
boolean
Alias
- UMLS CUI [1]
- C0045093
- UMLS CUI [2]
- C0210657
Description
Unable to take Folic Acid | Unable to take Vitamin B 12
Data type
boolean
Alias
- UMLS CUI [1,1]
- C4074979
- UMLS CUI [1,2]
- C0016410
- UMLS CUI [2,1]
- C4074979
- UMLS CUI [2,2]
- C0042845
Description
cancer treatment
Data type
boolean
Alias
- UMLS CUI [1]
- C0920425
Similar models
Eligibility Breast Cancer NCT00063570
- StudyEvent: Eligibility
C0144576 (UMLS CUI [2])
C0699967 (UMLS CUI [3])
C0246415 (UMLS CUI [4])
C1705242 (UMLS CUI [1,2])
C2939420 (UMLS CUI [1,3])
C1522449 (UMLS CUI [2])
C0564673 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
C0210657 (UMLS CUI [2])
C0016410 (UMLS CUI [1,2])
C4074979 (UMLS CUI [2,1])
C0042845 (UMLS CUI [2,2])